Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

Errata: Vol. 54, No. RR-16

In the MMWR Recommendations and Reports, "A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) --- Part 1: Immunization of Infants, Children, and Adolescents," the following errors occurred:

On page 8, in Table 2, in the first row, "Infants (<1 yr)," under the column heading "Combination vaccine, Pediarix, Dose (µg)," the text should read, "10."

On page 9, in Table 4, under the column heading "Recommendation," the second bullet should read, "Administer 3 additional hepatitis B vaccine doses with single-antigen vaccine at ages 1, 2--3, and 6 mos or hepatitis B-containing combination vaccine at ages 2, 4, and 6 mos (Pediarix) or 2, 4, and 12--15 mos (Comvax)."

The fourth bullet should read, "Test for HBsAg and antibody to HBsAg 1--2 mos after completion of >3 doses of a licensed hepatitis B vaccine series (i.e., at age 9--18 mos, generally at the next well-child visit). Testing should not be performed before age 9 mos nor within 4 wks of the most recent vaccine dose."

The seventh bullet should read, "Administer 3 additional hepatitis B vaccine doses with single-antigen vaccine at ages 1, 2--3, and 6 mos or hepatitis B-containing combination vaccine at ages 2, 4, and 6 mos (Pediarix) or 2, 4, and 12--15 mos (Comvax)."

The 10th bullet should read, "Complete the hepatitis B vaccine series with single-antigen vaccine at ages 2 mos and 6--18 mos or hepatitis B-containing combination vaccine at ages 2, 4, and 6 mos (Pediarix) or 2, 4, and 12--15 mos (Comvax)."

The following footnote should be added to Table 4: "The final dose in the vaccine series should not be administered before age 24 weeks (164 days)."

The corrected Table 4 is available in its entirety at http://www.cdc.gov/hepatitis/hbv/pdfs/correctedtable4.pdf.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Date last reviewed: 12/5/2007

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services